64226-67-1 Usage
Uses
Used in Pharmaceutical Research:
1-(20-oxopregn-5-en-3-yl)pyrimidine-2,4(1H,3H)-dione is used as a research compound for its potential biological activity. 1-(20-oxopregn-5-en-3-yl)pyrimidine-2,4(1H,3H)-dione is of interest to scientists working in the field of medicinal chemistry, as it may contribute to the development of new drugs and therapies.
Used in Drug Development:
In the pharmaceutical industry, 1-(20-oxopregn-5-en-3-yl)pyrimidine-2,4(1H,3H)-dione is used as a candidate molecule for drug development. Its complex structure and potential biological activity make it a promising starting point for the creation of new medications, pending further research into its properties and therapeutic effects.
Check Digit Verification of cas no
The CAS Registry Mumber 64226-67-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,2,2 and 6 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 64226-67:
(7*6)+(6*4)+(5*2)+(4*2)+(3*6)+(2*6)+(1*7)=121
121 % 10 = 1
So 64226-67-1 is a valid CAS Registry Number.
64226-67-1Relevant academic research and scientific papers
Synthesis of 3- and 6-substituted steroidal heterocycles as potential anticancer agents
Autenrieth,Kan,Van Lier
, p. 525 - 528 (2007/10/02)
Coupling via C-N linkage between 3-bromo- or 3-mesyl steroids and various heterocycles, including pyrimidines and imidazole derivatives, was accomplished by adapting general methods used in nucleoside synthesis. PMR evidence indicated the formation of the isomeric 3-substituted steroid derivatives, and in certain instances the formation of 6-substituted 3,5-cyclosteroids. Assessment was made of different steroid bromination methods. Presumptive activity against L-1210 lymphoid leukemia in female mice was observed for one of the isomers of 3-uracil-substituted 5-pregnen-20-one.
